Pacira BioSciences (PCRX) Interest Coverage Ratio (2010 - 2026)
Pacira BioSciences' (PCRX) quarterly Interest Coverage Ratio came in at 0.12 in Q1 2026, up 246.83% year-on-year from 0.03 in Q1 2025, and down 75.06% quarter-over-quarter from 0.48 in Q4 2025.
Pacira BioSciences (PCRX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Pacira BioSciences' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 0.12 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 246.83% year-over-year to 0.12 in Q1 2026; TTM through Mar 2026 was 0.42, a 128.49% increase from a year earlier, with the FY2025 full-year figure at 0.33, up 111.33% from the prior year.
- Interest Coverage Ratio slipped to 0.12 in Q1 2026 per PCRX's latest filing, from 0.48 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 12.27 in Q4 2023 and bottomed at 2.44 in Q3 2024.
- The 5-year median for Interest Coverage Ratio is 0.48 (2025), against an average of 2.28.
- Across the five-year window, Interest Coverage Ratio tumbled 1536.21% in 2022 and jumped 640.59% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 2.27 in 2022, then soared by 640.59% to 12.27 in 2023, then slumped by 43.4% to 6.94 in 2024, then slumped by 93.04% to 0.48 in 2025, then sank by 75.06% to 0.12 in 2026.
- Per Business Quant, the three latest PCRX Interest Coverage Ratio figures stand at 0.12 (Q1 2026), 0.48 (Q4 2025), and 0.11 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Pacira BioSciences | 1.05 Bn | 846.97 Mn | 140.96 Mn | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 0.48 |
| Sep 30, 2025 | 0.11 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 6.94 |
| Sep 30, 2024 | -2.44 |
| Jun 30, 2024 | 0.49 |
| Mar 31, 2024 | 0.23 |
| Dec 31, 2023 | 12.27 |
| Sep 30, 2023 | 5.11 |
| Jun 30, 2023 | 10.32 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -2.27 |
| Sep 30, 2022 | 2.16 |
| Jun 30, 2022 | 3.54 |
| Mar 31, 2022 | 1.70 |
| Dec 31, 2021 | 0.16 |
| Sep 30, 2021 | 4.29 |
| Jun 30, 2021 | 4.96 |